LongPODDAug 2026
Insulet Corporation
Insulet has a near-monopoly in insulin patch pumps through its Omnipod platform. Second-quarter revenue and earnings exceeded expectations, although management lowered 2026 US…
PODD
1 published idea on Insulet Corporation across 1 fund — 1 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Insulet: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Insulet has a near-monopoly in insulin patch pumps through its Omnipod platform. Second-quarter revenue and earnings exceeded expectations, although management lowered 2026 US…